Wållberg-Jonsson S, Dahlén G, Johnson O, Olivecrona G, Rantapää-Dahlqvist S
Department of Rheumatology, University Hospital, Umeå, Sweden.
J Intern Med. 1996 Dec;240(6):373-80. doi: 10.1046/j.1365-2796.1996.53873000.x.
To evaluate the impact of chronic inflammation on lipoprotein lipase (LPL) levels and tri-glyceride metabolism in patients wit rheumatoid arthritis (RA).
Plasma levels of LPL activity and mass before and after heparin were determined in post-menopausal women with active RA and in controls. The results were related to lipid levels and inflammatory variables. The LPL activity and mass together with triglyceride levels were also measured before and 6 h after an oral fat load.
The study was performed on in- and outpatients at a University Rheumatology clinic. The controls came from the same reference area.
Altogether 17 consecutive postmenopausal female patients with RA and 16 age and sex matched controls were enrolled for the initial determination of LPL. Fifteen of the patients and 15 of the controls agreed to take part in the fat load. Of these, one patient and one control were excluded.
LPL determination: basal levels and post-heparin levels of LPL activity and mass. Correlations between LPL and blood lipids (cholesterol, triglycerides), lipoprotein levels (high density lipoprotein, HDL: low density lipoprotein, LDL), erythrocyte sedimentation rate (ESR) acute phase proteins (orosomucoid, haptoglobin, fibrinogen mass) and cytokines (tumour necrosis factor alpha. TNF-alpha: interleukin 1 beta, IL-1 beta: and interleukin-6. IL-6). Fat tolerance test: LPL activity. mass and triglyceride levels before and 6 h after a per oral fat load.
Pre-heparin LPL mass (P < 0.01) and activity (P < 0.01) were significantly lower in the rheumatoid patients. Pre-heparin LPL mass showed no correlation to the lipid levels, but an inverse correlation to several inflammatory parameters: it was significant for orosomucoid (rs = -0.63, P < 0.05) and C-reactive protein (CRP) (rs = -0.54, P < 0.05) and close to significant for haptoglobin (rs = -0.48, P = 0.087) and IL-6 (rs = -0.52, P = 0.061). Six hours after.a lipid load the LPL activity and mass were significantly lower in RA (P < 0.05 and P < 0.01, respectively) but the triglyceride level was not significantly different compared to controls.
An inverse relationship exists between inflammatory status and pre-heparin LPL mass. Preheparin LPL mass reflects mainly the inactive monomeric fraction of LPL. This has been shown to hinder the uptake of remnant lipoprotein particles through competition with lipoprotein bound dimeric LPL for the LDL receptor-related protein (LRP receptor) on hepatocytes and macrophages in culture. A decrease of the level of monomeric LPL in plasma may thus be beneficial for remnant catabolism. The same mechanism may on the other hand increase macrophage uptake of lipids. This may not affect global lipid metabolism but may be important in driving the atherosclerotic process in the vessel wall.
评估慢性炎症对类风湿关节炎(RA)患者脂蛋白脂肪酶(LPL)水平及甘油三酯代谢的影响。
测定绝经后活动性RA女性患者及对照组肝素使用前后血浆中LPL活性和质量水平。结果与血脂水平及炎症变量相关。还在口服脂肪负荷前及6小时后测定LPL活性、质量及甘油三酯水平。
该研究在一所大学风湿病诊所的门诊及住院患者中进行。对照组来自同一参考区域。
共纳入17例连续的绝经后女性RA患者及16例年龄和性别匹配的对照者进行LPL的初始测定。15例患者和15例对照者同意参与脂肪负荷试验。其中,1例患者和1例对照者被排除。
LPL测定:LPL活性和质量的基础水平及肝素使用后水平。LPL与血脂(胆固醇、甘油三酯)、脂蛋白水平(高密度脂蛋白、HDL;低密度脂蛋白、LDL)、红细胞沉降率(ESR)、急性期蛋白(类粘蛋白、触珠蛋白、纤维蛋白原质量)及细胞因子(肿瘤坏死因子α、TNF-α;白细胞介素1β、IL-1β;及白细胞介素-6、IL-6)之间的相关性。脂肪耐量试验:口服脂肪负荷前及6小时后LPL活性、质量及甘油三酯水平。
类风湿患者肝素使用前LPL质量(P<0.01)和活性(P<0.01)显著降低。肝素使用前LPL质量与血脂水平无相关性,但与多个炎症参数呈负相关:与类粘蛋白(rs=-0.63,P<0.05)和C反应蛋白(CRP)(rs=-0.54,P<0.05)显著相关,与触珠蛋白(rs=-0.48,P=0.087)和IL-6(rs=-0.52,P=0.061)接近显著相关。脂肪负荷6小时后,RA患者的LPL活性和质量显著降低(分别为P<0.05和P<0.01),但甘油三酯水平与对照组相比无显著差异。
炎症状态与肝素使用前LPL质量之间存在负相关。肝素使用前LPL质量主要反映LPL的非活性单体部分。研究表明,这部分通过与脂蛋白结合的二聚体LPL竞争肝细胞和巨噬细胞上的低密度脂蛋白受体相关蛋白(LRP受体),阻碍残余脂蛋白颗粒的摄取。因此,血浆中单体LPL水平的降低可能有利于残余物分解代谢。另一方面,相同机制可能增加巨噬细胞对脂质的摄取。这可能不影响整体脂质代谢,但可能在驱动血管壁动脉粥样硬化进程中起重要作用。